Any company that wants to produce medical cannabis or its derivatives in Uruguay, has to be approved in a series of steps within the regulatory bodies of the country, including the Ministry Of Agriculture (MGAP), the Cannabis Regulatory Institute (IRCCA) and the National Anti-money Laundering Bureau (SENACLAFT).
These organs analyze and inspect the feasibility of the project, the proponent’s financial capacity, the origin of the money to be invested and the monitoring of the process. For each type of project (cultivation, processing, export, etc) there’s a specific authorization.
Uruguay Food Labs SAS, based in the Free Zone of Florida, has indoor cultivation areas (medicinal THC), industrialization and logistics (raw material, derivatives and final products of Cannabis); Taking advantage of the fiscal and commercial benefits for the market provided by the Free Zone.
Anna was born with the purpose of demystifying the access and use of Medicinal Cannabis, promoting quality of life, well-being and safety for patients who are looking for the best and most advanced in the Cannabis market.
Our Current Market View 1
According to the Associação Brasileira das Indústrias de Cannabis, with data taken from Euromonitor, cannabis for therapeutic purposes can reach up to 18 million patients, and today, in Brazil, the Federation of Associations of Cannabis Therapeutics estimates that only 50 thousand people have access to products derived from cannabis, both through importation and products coming from associations.
Our Current Market View 2
From January 2021 to November of the same year, US$ 5,450,791.00 were imported, 40% more than the previous year. IstoÉ Dinheiro estimates that in 2020, around 80 million reais in cannabidiol products were traded. By 2020, it was estimated that only 2,100 doctors were prescribing medical cannabis. Import orders for cannabis-derived products grew 1,766 times between the years 2014 to 2020.
Requests with ANVISA year by year:
2018 – 3,517;
2019 – 8,522;
2020 – 15,862;
2021 – 19,145.
Florelar Brasil LTDA is an Importer and Distributor of medicines regulated and authorized by ANVISA. Headquartered in Curitiba-PR since 2020.
Company chosen by Tecpar (Instituto Tecnológico do Estado do Paraná/BR) to supply the Public Health System and develop raw materials and Cannabis derivatives for finished products to be distributed in Brazil.
• Co-founder of the company
• Graduated at Universidad de la
República de Uruguay
• Bachelor's and PhD in Medicine
• Expert in cannabis cultivation
• Knowledge of endocannabinoid
medicine
• Entrepreneur
• Angel investor
• Co-founder of the company
• Graduated at Universidad de la República de Uruguay.
• Bachelor’s in Economy
• Entrepreneur
• 40 Years experience at the Latin America financial market
• Angel investor
• Cultivation Technical Director
• Graduated at UDELAR
• Bachelor’s and PhD in Agronomy
• Titular Professor of hydroponic grow at Universidad de la Empresa, UY
• Director of the Department of Planning and Production of Uruguay
• Expert in hydroponic grow
• Expert in Cannabis cultivation
• Click here for more information
• International Business Manager
• Graduated in International business at UNISUL
• Responsible for regulatory management
• Expert in exports, imports and logistics
• Supply chain and operations management
Afonso Braga Filho, Afonso Braga Neto and Alfonso Cardozo Ferretjans
Promise, we won't stay silent